Viewing Study NCT06268860


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2025-12-27 @ 11:36 PM
Study NCT ID: NCT06268860
Status: COMPLETED
Last Update Posted: 2025-12-23
First Post: 2024-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants
Sponsor: Amgen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-02-15
Start Date Type: ACTUAL
Primary Completion Date: 2024-08-30
Primary Completion Date Type: ACTUAL
Completion Date: 2024-10-08
Completion Date Type: ACTUAL
First Submit Date: 2024-02-13
First Submit QC Date: None
Study First Post Date: 2024-02-20
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-19
Last Update Post Date: 2025-12-23
Last Update Post Date Type: ESTIMATED